Journal of Stem Cell Research & Therapy

Generation of a biologically and mechanically suitable 3D scaffold for heart valve

Annual Summit on Cell Signaling, Cell Therapy and Cancer Therapeutics

September 27-28, 2017 Chicago, USA

Maryam Eslami, Ali Khademhosseini, Gholamreza Javadi, Nasser Agdami and Mohammad Ali Shokrgozar

Islamic Azad University, Iran
Brigham and Womenâ??s Hospital, USA
Massachusetts Institute of Technology, USA
Harvard University, Boston, USA
Royan Institute for Stem Cell Biology and Technology, Iran
Pasteur Institute of Iran (IPI), Iran

Scientific Tracks Abstracts: J Stem Cell Res Ther

Abstract:

Introduction: Heart valve disease is one of the most important causes of mortality in the world. Although prosthetic valves have been widely used, prosthetic which grows with patient, maintains normal valve mechanical properties and hemodynamic flow has not been innovated. Tissue engineering offers exciting opportunity to engineer heart valves using biodegradable scaffolds and patients own cells. Heart valves are made up of spatially organized extracellular matrix (ECM) which consists of fibrous collagen and elastin and highly hydrated glycosaminoglycan. Valve interstitial cells (VICs) are the major cell types responsible for ECM remodeling in healthy valves. Elastin, proteoglycan and collagen-rich layers are the most important components of the ECM of valves. These elements due to distinct biomechanical properties to the leaflets and supporting structures. Objective: The objective of this workshop is generation of a proper 3D scaffold by mimicking heart valve structure. Procedures: We want to show how integrated electrospun poly(glycerol sebacate) (PGS)-poly(ε-caprolactone) (PCL) microfiber scaffolds -reinforce hydrogel scaffolds for heart valve tissue engineering by use of methacrylatedhyaluronic acid (HAMA) and methacrylated gelatin (GelMA). Hyaluronic acid is selected because it plays an important role during in heart valve morphogenesis. To enhance cellular properties, denatured collagen in form of GelMA will be added to HAMA. Hypothetical of this technic is that hydrogels provide an ECM in-vivo mimicking environment and is an efficient means of encapsulating cells in desired density on the fibrous scaffolds. On the other hand, elastomeric PGS-PCL scaffolds will provide appropriate mechanical properties to otherwise weak hydrogel scaffolds. Presence of HA will promote secretion of elastin by valve interstitial cells (VICs). After teaching how to design and make this kind of composite and how to encapsulate VICs necessary biological and mechanical tests and analyzes will be taught and discussed. Conclusions: The composite scaffold synthesis in this workshop will overcome some of the limitations of current materials use for heart valve tissue engineering. The participants will observe that the hydrogel component provides an ECM-mimicking environment and efficient means of Vicâ??s cell delivery to the scaffold, while the fibrous PGS-PCL mesh maintains the cellsâ?? viability, allowing them to spread and distribute themselves within the hydrogel by providing appropriate mechanical properties to the otherwise weak hydrogel scaffolds. Furthermore, adding the hydrogel component will not adversely affect the scaffoldâ??s mechanical properties based on the similar values of both Young's modulus and the ultimate tensile strength of the bare PGS/PCL scaffolds and the composites. The mechanical and biological advantages of this composite scaffold can motivate further studies using this technology for potential application in heart valve tissue engineering. We hopefully look forward the participants to learning more about design of heart valve scaffolds and will be motivated to generate the most useful scaffold for the patients.The following parts will be tough in this workshop: Design and synthesis of proper composite; encapsulation of VICs by composite; performance of appropriate biological and mechanical test and; analysis of results of result.

Biography :

Maryam Eslami graduated with MD (2010), PhD (2014) degrees. She has joined in Harvard Medical School (Harvard-MIT Division of Health Sciences and Technology) as a part of her PhD dissertation in the field of Heart valve. She has carried out some broad research on orthopedic fractures and has published a book and papers in this field. Her US and PCT patent achieved the rank of “Best 2008 Invention” from WIPO (World Intellectual Property Organization of the United Nations) and has received the title of "Best 2008 Women Inventor" from WIPO and 6 Gold Medals and 6 Honorary Diplomas in the Contests and Fair of the Inventors in Geneva and South Korea. International and national awards for her research were one of the fundamental achievements that she has received. She now serves as a President of Applied Biotechnology Research Institute and previously was a research Vice President of Paramedical School at Tehran Azad Medical University.